A PHASE II STUDY OF LOW DOSE ARSENIC TRIOXIDE IN PATIENTS WITH MALIGNANCIES AS A POTENTIAL CHEMOTHERAPY PROTECTOR

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Ha,Chul Soo

Funded by

CHEMO PROTECTIVE R&D CORP.

Research Start Date

01/01/2017

Status

Inactive

Clinical Care

Drug Discovery

Cancer

Bioscience Research Panel